Neumann I, Thierau D, Andrae U, Greim H, Schwarz L R
GSF-Institut für Toxikologie, Neuherberg, FRG.
Carcinogenesis. 1992 Mar;13(3):373-8. doi: 10.1093/carcin/13.3.373.
The synthetic anti-androgen and progestin cyproterone acetate (CPA) is known to increase the liver tumor rate in rats. The tumorigenicity of CPA has been attributed to a tumor-promoting activity of the steroid. In order to discover whether CPA acts directly on preneoplastic liver cells or via indirect effects, we investigated whether CPA stimulates replicative DNA synthesis in vitro in hepatocytes isolated from carcinogen-treated rats (two-thirds hepatectomy, 1 x 30 mg diethylnitrosamine per kg and 0.1% phenobarbital in the drinking water) and whether the degree of stimulation differs in gamma-glutamyltranspeptidase (GGT)-positive, putatively preneoplastic and GGT-negative, 'normal' hepatocytes. The possibility that CPA might also have initiating potential was investigated by studying its effects on DNA repair synthesis. Stimulation of [3H]thymidine incorporation into the DNA by CPA was only observed in the presence of epidermal growth factor (EGF) (10 ng/ml) and insulin (10 mU/ml). Maximal effects were obtained between 2 and 10 microM. DNA synthesis in the presence of EGF/insulin was reduced by the 'pure' anti-androgen flutamide, but stimulated by the 'pure' progestin promegestone. In the presence of CPA, EGF and insulin, the labelling index was twice as high in GGT-positive as in GGT-negative liver cells, regardless of whether mitogens were added at 48 or 72 h. The labelling index did not differ in the GGT-positive and negative hepatocytes when CPA was omitted. These findings are consistent with the idea that CPA has tumor-promoting activity. CPA significantly induced repair synthesis in the isolated hepatocytes from both untreated and carcinogen-treated rats. This increase was detected at a concentration as low as 2 microM and maximal effects were obtained at 20 microM. These results indicate that CPA is not only a tumor-promoting, but also a genotoxic chemical, i.e. that it might also have an initiating potential.
合成抗雄激素和孕激素醋酸环丙孕酮(CPA)已知会增加大鼠的肝脏肿瘤发生率。CPA的致瘤性归因于该类固醇的促肿瘤活性。为了探究CPA是直接作用于癌前肝细胞还是通过间接作用,我们研究了CPA是否能在体外刺激从经致癌物处理的大鼠(三分之二肝切除术,每千克体重注射1×30毫克二乙基亚硝胺并在饮用水中添加0.1%苯巴比妥)分离的肝细胞中的复制性DNA合成,以及刺激程度在γ-谷氨酰转肽酶(GGT)阳性、推测为癌前的肝细胞和GGT阴性的“正常”肝细胞中是否存在差异。通过研究CPA对DNA修复合成的影响,探究了其是否也具有启动潜能。仅在存在表皮生长因子(EGF,10纳克/毫升)和胰岛素(10毫单位/毫升)的情况下观察到CPA刺激[3H]胸腺嘧啶掺入DNA。在2至10微摩尔之间可获得最大效应。“纯”抗雄激素氟他胺可降低EGF/胰岛素存在时的DNA合成,但“纯”孕激素普美孕酮可刺激DNA合成。在存在CPA、EGF和胰岛素的情况下,无论在48小时还是72小时添加有丝分裂原,GGT阳性肝细胞中的标记指数都是GGT阴性肝细胞中的两倍。省略CPA时,GGT阳性和阴性肝细胞中的标记指数没有差异。这些发现与CPA具有促肿瘤活性的观点一致。CPA显著诱导了未处理和经致癌物处理的大鼠分离肝细胞中的修复合成。在低至2微摩尔的浓度下即可检测到这种增加,在20微摩尔时可获得最大效应。这些结果表明,CPA不仅是一种促肿瘤化学物质,也是一种遗传毒性化学物质,即它可能也具有启动潜能。